These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure. Petein M, Levine TB, Cohn JN. Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778 [Abstract] [Full Text] [Related]
4. [Acute effect of enoximone and captopril in patients with heart failure]. Scholz M, Kneissl GD, Dieterich HA, Kaltenbach M, Bussmann WD. Z Kardiol; 1991 Mar; 80 Suppl 4():69-74. PubMed ID: 1833901 [Abstract] [Full Text] [Related]
5. [Acute and chronic effects of UDCG 115 BS (pimobendan) in patients with advanced myocardial failure]. Permanetter B, Baumann G, Wirtzfeld A, Günes S, Stinshoff M, Klein G. Z Kardiol; 1989 May; 78(5):335-42. PubMed ID: 2660451 [Abstract] [Full Text] [Related]
6. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W. Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617 [Abstract] [Full Text] [Related]
8. [Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency]. Korewicki J, Rajecka A, Pogorzelska H, Madeja G. Kardiol Pol; 1990 Jul; 33(6):365-74. PubMed ID: 2128094 [Abstract] [Full Text] [Related]
9. [Comparison of new cardiac agents using differential therapeutic criteria]. Redmann K, Lunkenheimer PP, Rettig G, Isringhaus H, Flameng W, Demeyere R. Z Kardiol; 1991 Jul; 80 Suppl 4():7-14. PubMed ID: 1833902 [Abstract] [Full Text] [Related]
10. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency]. Lellouche D, Delorme G, Merlet P, Dubois-Randé JL, Duval AM, Tarral A, Bourdarias JP, Vernant P. Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777 [Abstract] [Full Text] [Related]
12. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. Hermiller JB, Leithe ME, Magorien RD, Unverferth DV, Leier CV. J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112 [Abstract] [Full Text] [Related]
13. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure]. Gun C, Piegas LS, Bianco AC, Freire RB, Ramos RF, Timerman A. Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514 [Abstract] [Full Text] [Related]
14. Acute clinical benefits of a new inotropic agent AR-L 115 BS after i.v. and oral administration. el Allaf D, D'Orio V, Cremers S, Carlier J. G Ital Cardiol; 1984 Oct; 14(10):830-4. PubMed ID: 6519393 [Abstract] [Full Text] [Related]
15. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure. Pflugfelder PW, O'Neill BJ, Ogilvie RI, Beanlands DS, Tanser PH, Tihal H, Mizgala HF, Fitchett DH, Kostuk WJ. Can J Cardiol; 1991 Oct; 7(1):5-10. PubMed ID: 2025794 [Abstract] [Full Text] [Related]
16. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?]. Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U. Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699 [Abstract] [Full Text] [Related]
17. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure. Hauf GF, Bubenheimer P, Roskamm H. Arzneimittelforschung; 1981 Dec; 31(1a):253-6. PubMed ID: 7195235 [Abstract] [Full Text] [Related]
18. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure]. La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A. G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168 [Abstract] [Full Text] [Related]
19. Acute effects of enoximone in chronic heart failure. Saborowski F, Peters P, Schneider M, Fehske W, Dieterich HA. J Cardiovasc Pharmacol; 1989 Aug; 14 Suppl 1():S57-61. PubMed ID: 2480487 [Abstract] [Full Text] [Related]
20. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy. Di Mario C, Compostella L, Iavernaro A, Libardoni M, Ghirardi P, Cucchini F. Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]